Investor's Business Daily96d agoneutral
The Merck Product That Absolutely Demolished Wall Street's ForecastsNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily114d agoneutral
Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies.Yahoo Personal Finance115d agoneutral
FDA approves first-of-its-kind cholesterol pill Lipfendra: What it will costThe Wall Street Journal115d agoneutral
Merck’s First-of-Its-Kind Cholesterol Pill Approved, Ushering in New Wave of TreatmentInvestor's Business Daily129d agoneutral
Merck Stock, JPMorgan And Two Others Hit New HighsThe Wall Street Journal135d agoneutral
Moderna Shares Up on New Research Efforts for Autoimmune DisorderThe Wall Street Journal136d agoneutral
Germany’s Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal